Effect of BCG vaccination for tuberculosis on COVID-19 in Brazil

Not Applicable

• Conditions: COVID-19 (SARS-CoV-2 infection) in persons who were previously given the BCG vaccine; Infections and Infestations

• Registration Number: ISRCTN47802196
• Lead Sponsor: ational Council for Scientific and Technological Development

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-05-19
• Last Update Posted: 7 June 2021
• Study Completion: 2021-12-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 200805

Inclusion Criteria

Participants from the BCGREVAC trial (1996 - 1998) who were diagnosed or died from COVID-19 from January 27, 2020, onwards.

Exclusion Criteria

Does not meet inclusion criteria.

Study & Design

• Study Type: Interventional
• Study Design: Not specified